Comparison of two dose regimens of growth hormone (GH) with different target IGF-1 levels on glucose metabolism, lipid profile, cardiovascular function and anthropometric parameters in gh-deficient adults

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
Maria Claudia Peixoto CenciFlávia Lúcia Conceição

Abstract

To compare the effects of two regimens of GH therapy with different target IGF-1 levels on anthropometric parameters, glucose metabolism, lipid profile and cardiac function in adults with GH deficiency (GHD). Retrospective analysis of 14 GHD adults from Clementino Fraga Filho University Hospital, Rio de Janeiro, Brazil, who were treated with a GH regimen aimed at maintaining serum IGF-1 levels between the median and upper reference limit (high dose group - HDGH) and 18 GHD adults from Federal University Hospital, Curitiba, Brazil, who received a fixed GH dose of 0.2mg/day in the first year of treatment, followed by titration to maintain serum IGF-1 levels between the median and lower reference limit (low dose group - LDGH). All patients were followed for 2 years with analysis of anthropometric parameters, serum levels of IGF-1, glucose, insulin, HOMA-IR, lipid profile, and transthoracic echocardiography. Changes on weight, BMI and waist circumference were similar between the two groups. Insulin levels increased and HOMA-IR worsened in the LDGH group at 1year and improved thereafter. Total cholesterol and triglycerides did not change with therapy. LDL cholesterol reduced in both groups, while HDL-cholesterol significantly increa...Continue Reading

References

Feb 15, 1986·The American Journal of Cardiology·R B DevereuxN Reichek
Feb 1, 1995·The Journal of Clinical Endocrinology and Metabolism·R ValcaviI Portioli
Dec 1, 1993·The Journal of Clinical Endocrinology and Metabolism·B MerolaG Lombardi
Mar 9, 1999·European Journal of Endocrinology·G P LeeseI A MacFarlane
Aug 12, 1999·The Journal of Clinical Endocrinology and Metabolism·J GibneyD Russell-Jones
Nov 4, 2000·The Journal of Clinical Endocrinology and Metabolism·A ChrisoulidouD G Johnston
Dec 12, 2001·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·P GillbergG Johannsson
May 8, 2002·The Journal of Clinical Endocrinology and Metabolism·Johan SvenssonJan-Ove Johansson
Jan 1, 2004·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Luciana Diniz Carneiro SpinaMário Vaisman
May 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Patrick MaisonUNKNOWN Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials
Nov 3, 2004·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·D V SoaresM Vaisman
Mar 28, 2006·The American Journal of Cardiology·Vicente E ClimentFrancisco Marín
Apr 26, 2006·The Journal of Clinical Endocrinology and Metabolism·Mark E MolitchPatricia A Stephens
Dec 15, 2007·Metabolism: Clinical and Experimental·Maria Claudia Peixoto CenciMario Vaisman
Apr 10, 2008·The Journal of Clinical Endocrinology and Metabolism·Agatha A van der KlaauwJohannes A Romijn
Oct 12, 2010·The Journal of Clinical Endocrinology and Metabolism·Connie B NewmanDavid L Kleinberg
Nov 26, 2010·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Christin SpielhagenHenri Wallaschofski
Feb 8, 2011·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·A P JørgensenJ Bollerslev
May 24, 2011·The Journal of Clinical Endocrinology and Metabolism·Mark E MolitchUNKNOWN Endocrine Society

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.